×




Tengion: Bringing Regenerative Medicine to Life Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Tengion: Bringing Regenerative Medicine to Life case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Tengion: Bringing Regenerative Medicine to Life case study is a Harvard Business School (HBR) case study written by Elie Ofek, Polly Ross Ribatt. The Tengion: Bringing Regenerative Medicine to Life (referred as “Tengion Treatments” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, Entrepreneurial management, Market research, Pricing, Product development, Recession.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Tengion: Bringing Regenerative Medicine to Life Case Study


Tengion is a young biotech company that is at the frontier of regenerative medicine; a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late 2008 Tengion management faces a difficult dilemma. In light of the financial crises, the company needs to manage cash burn by prioritizing its R&D efforts. CEO Nichtberger needs to recommend to the board which of two promising new medical treatments to keep developing while placing the other on hold. In comparing the two options, a host of factors need to be considered-- these range from assessing the regulatory challenges, manufacturing challenges, marketing challenges (in particular pricing), and partnering challenges. Each of the treatments would target a unique patient population, that differ in both size and composition. Tengion must also consider how quickly it might expect to bring each of the two treatments to market. The decision could have significant long-term implications for the company's ultimate survival and success.


Case Authors : Elie Ofek, Polly Ross Ribatt

Topic : Sales & Marketing

Related Areas : Entrepreneurial management, Market research, Pricing, Product development, Recession




Calculating Net Present Value (NPV) at 6% for Tengion: Bringing Regenerative Medicine to Life Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10026441) -10026441 - -
Year 1 3444221 -6582220 3444221 0.9434 3249265
Year 2 3955736 -2626484 7399957 0.89 3520591
Year 3 3952193 1325709 11352150 0.8396 3318337
Year 4 3235380 4561089 14587530 0.7921 2562724
TOTAL 14587530 12650918




The Net Present Value at 6% discount rate is 2624477

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Payback Period
3. Internal Rate of Return
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Tengion Treatments shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Tengion Treatments have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Tengion: Bringing Regenerative Medicine to Life

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Tengion Treatments often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Tengion Treatments needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10026441) -10026441 - -
Year 1 3444221 -6582220 3444221 0.8696 2994975
Year 2 3955736 -2626484 7399957 0.7561 2991105
Year 3 3952193 1325709 11352150 0.6575 2598631
Year 4 3235380 4561089 14587530 0.5718 1849839
TOTAL 10434550


The Net NPV after 4 years is 408109

(10434550 - 10026441 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10026441) -10026441 - -
Year 1 3444221 -6582220 3444221 0.8333 2870184
Year 2 3955736 -2626484 7399957 0.6944 2747039
Year 3 3952193 1325709 11352150 0.5787 2287149
Year 4 3235380 4561089 14587530 0.4823 1560272
TOTAL 9464644


The Net NPV after 4 years is -561797

At 20% discount rate the NPV is negative (9464644 - 10026441 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Tengion Treatments to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Tengion Treatments has a NPV value higher than Zero then finance managers at Tengion Treatments can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Tengion Treatments, then the stock price of the Tengion Treatments should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Tengion Treatments should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What will be a multi year spillover effect of various taxation regulations.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Tengion: Bringing Regenerative Medicine to Life

References & Further Readings

Elie Ofek, Polly Ross Ribatt (2018), "Tengion: Bringing Regenerative Medicine to Life Harvard Business Review Case Study. Published by HBR Publications.


Toscana Aeroporti SWOT Analysis / TOWS Matrix

Transportation , Misc. Transportation


Oxatis SWOT Analysis / TOWS Matrix

Services , Retail (Catalog & Mail Order)


Yanghe Brewery A SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Beverages (Alcoholic)


Enzumo SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Ratu Prabu Energi SWOT Analysis / TOWS Matrix

Energy , Oil Well Services & Equipment


Hanil Feed SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Uniper SE SWOT Analysis / TOWS Matrix

Utilities , Electric Utilities


Danone SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Ohba SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services